Literature DB >> 1733949

Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

M L Stracke1, H C Krutzsch, E J Unsworth, A Arestad, V Cioce, E Schiffmann, L A Liotta.   

Abstract

Autotaxin (ATX) is a potent human motility-stimulating protein that has been identified in the conditioned medium from A2058 melanoma cells. This protein has been purified to homogeneity utilizing a strategy involving five column steps. Homogeneity of ATX was verified by two-dimensional gel electrophoresis. The molecular size of ATX is 125 kDa, and it has an isoelectric point of 7.7 +/- 0.2. Purified ATX was digested with cyanogen bromide and trypsin, and the resulting ATX peptides were purified by reverse-phase high performance liquid chromatography. Eleven peptides were subjected to amino acid sequence analysis, and 114 residues were identified. The partial amino acid sequences and the amino acid composition obtained for ATX show that it does not exhibit any significant homology to known growth factors or previously described motility factors. At picomolar concentrations, ATX stimulates both random and directed migration of human A2058 melanoma cells. Pretreatment of the melanoma cells with pertussis toxin abolishes the response to purified ATX, indicating that ATX stimulates motility through a receptor acting via a pertussis toxin-sensitive G protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733949

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  185 in total

1.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

Review 3.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

4.  Ligand-based autotaxin pharmacophore models reflect structure-based docking results.

Authors:  Catrina D Mize; Ashley M Abbott; Samantha B Gacasan; Abby L Parrill; Daniel L Baker
Journal:  J Mol Graph Model       Date:  2011-09-18       Impact factor: 2.518

5.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

Review 6.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

7.  Lysophosphatidic acid produced by hen egg white lysophospholipase D induces vascular development on extraembryonic membranes.

Authors:  Junichi Morishige; Yoshihiro Uto; Hitoshi Hori; Kiyoshi Satouchi; Tanihiro Yoshiomoto; Akira Tokumura
Journal:  Lipids       Date:  2013-02-06       Impact factor: 1.880

8.  Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.

Authors:  Gilles Ferry; Edwige Tellier; Anne Try; Sandra Grés; Isabelle Naime; Marie Françoise Simon; Marianne Rodriguez; Jérémie Boucher; Ivan Tack; Stéphane Gesta; Pascale Chomarat; Marc Dieu; Martine Raes; Jean Pierre Galizzi; Philippe Valet; Jean A Boutin; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

9.  Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design.

Authors:  Spencer B Jones; Lance A Pfeifer; Thomas J Bleisch; Thomas J Beauchamp; Jim D Durbin; V Joseph Klimkowski; Norman E Hughes; Christopher J Rito; Yen Dao; Joseph M Gruber; Hai Bui; Mark G Chambers; Srinivasan Chandrasekhar; Chaohua Lin; Denis J McCann; Daniel R Mudra; Jennifer L Oskins; Craig A Swearingen; Kannan Thirunavukkarasu; Bryan H Norman
Journal:  ACS Med Chem Lett       Date:  2016-08-02       Impact factor: 4.345

10.  Reduced expression of autotaxin predicts survival in uveal melanoma.

Authors:  Arun D Singh; Karen Sisley; Yaomin Xu; Jianbo Li; Pieter Faber; Sarah J Plummer; Hardeep S Mudhar; Ian G Rennie; Patricia M Kessler; Graham Casey; Bryan G Williams
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.